Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000932471-17-002371
Filing Date
2017-02-13
Accepted
2017-02-13 06:15:29
Documents
1

Document Format Files

Seq Description Document Type Size
1 sciclonepharmaceuticalsinc.htm SC 13G 46926
  Complete submission text file 0000932471-17-002371.txt   48432
Mailing Address PO BOX 2600 V26 VALLEY FORGE PA 19482-2600
Business Address PO BOX 2600 V26 VALLEY FORGE PA 19482-2600 6106691000
VANGUARD GROUP INC (Filed by) CIK: 0000102909 (see all company filings)

EIN.: 231945930 | State of Incorp.: PA | Fiscal Year End: 1231
Type: SC 13G

Mailing Address 950 TOWER LANE SUITE 900 FOSTER CITY CA 94404-2125
Business Address 950 TOWER LANE SUITE 900 FOSTER CITY CA 94404-2125 650-358-3456
SCICLONE PHARMACEUTICALS INC (Subject) CIK: 0000880771 (see all company filings)

EIN.: 943116852 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-43408 | Film No.: 17595651
SIC: 2834 Pharmaceutical Preparations